115 related articles for article (PubMed ID: 9055187)
1. Renal excretion of vancomycin in rats with acute renal failure.
Nakamura T; Kokuryo T; Takano M; Inui K
J Pharm Pharmacol; 1997 Feb; 49(2):154-7. PubMed ID: 9055187
[TBL] [Abstract][Full Text] [Related]
2. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat.
Mahmood I; Waters DH
Eur J Drug Metab Pharmacokinet; 1994; 19(4):327-36. PubMed ID: 7737234
[TBL] [Abstract][Full Text] [Related]
4. Renal handling of drugs in renal failure. I: Differential effects of uranyl nitrate- and glycerol-induced acute renal failure on renal excretion of TEAB and PAH in rats.
Lin JH; Lin TH
J Pharmacol Exp Ther; 1988 Sep; 246(3):896-901. PubMed ID: 3418518
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vancomycin disposition in rats with normal and abnormal renal functions.
Engineer MS; Ho DH; Bodey GP
Antimicrob Agents Chemother; 1981 Dec; 20(6):718-22. PubMed ID: 7325638
[TBL] [Abstract][Full Text] [Related]
6. Moment analysis of drug disposition in kidney. III: Transport of p-aminohippurate and tetraethylammonium in the perfused kidney isolated from uranyl nitrate-induced acute renal failure rats.
Tanigawara Y; Saito Y; Aiba T; Ohoka K; Kamiya A; Hori R
J Pharm Sci; 1990 Mar; 79(3):249-56. PubMed ID: 2338636
[TBL] [Abstract][Full Text] [Related]
7. Decreased systemic clearance of diltiazem with increased hepatic metabolism in rats with uranyl nitrate-induced acute renal failure.
Lee YH; Lee MH; Shim CK
Pharm Res; 1992 Dec; 9(12):1599-606. PubMed ID: 1488404
[TBL] [Abstract][Full Text] [Related]
8. Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate.
Han SY; Yang SH; Yoon I; Lee MG; Choi YH
J Pharm Pharmacol; 2012 Oct; 64(10):1452-60. PubMed ID: 22943176
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats.
Nagashima K; Kusaka H; Karasawa A
Jpn J Pharmacol; 1995 Apr; 67(4):349-57. PubMed ID: 7650867
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats.
Lee AK; Kim EJ; Lee MG
Res Commun Mol Pathol Pharmacol; 2003; 113-114():193-200. PubMed ID: 15686118
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.
Kim SH; Shim HJ; Kim WB; Lee MG
Antimicrob Agents Chemother; 1998 May; 42(5):1217-21. PubMed ID: 9593153
[TBL] [Abstract][Full Text] [Related]
12. Altered intravenous pharmacokinetics of topotecan in rats with acute renal failure (ARF) induced by uranyl nitrate: do adenosine A1 antagonists (selective/non-selective) normalize the altered topotecan kinetics in ARF?
Mustafa S; Venkatesh P; Pasha K; Mullangi R; Srinivas NR
Xenobiotica; 2006 Dec; 36(12):1239-58. PubMed ID: 17162470
[TBL] [Abstract][Full Text] [Related]
13. Influence of acute renal failure on pharmacokinetics of phenolsulfonphthalein in rats: a comparative study in vivo and in the simultaneous perfusion system of liver and kidney.
Yasuhara M; Katayama H; Fujiwara J; Okumura K; Hori R
J Pharmacobiodyn; 1985 May; 8(5):377-84. PubMed ID: 4045695
[TBL] [Abstract][Full Text] [Related]
14. Increased availability of propranolol in rats with uranyl nitrate-induced acute renal failure.
Katayama H; Fujiwara J; Yasuhara M; Okumura K; Hori R
J Pharmacobiodyn; 1984 Aug; 7(8):536-44. PubMed ID: 6512676
[TBL] [Abstract][Full Text] [Related]
15. Effect of acute renal failure on insulin disposition in the isolated perfused rat kidney.
Brier ME; Aronoff GR; Mayer PR
Am J Physiol; 1987 Nov; 253(5 Pt 2):F884-8. PubMed ID: 3318499
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing.
Venkatesh P; Harisudhan T; Choudhury H; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2007; 32(4):189-96. PubMed ID: 18348467
[TBL] [Abstract][Full Text] [Related]
17. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies.
Lee DY; Jung YS; Shin HS; Lee I; Kim YC; Lee MG
J Pharm Pharmacol; 2008 Jul; 60(7):843-51. PubMed ID: 18549670
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.
Maiza A; Daley-Yates PT
J Pharmacokinet Biopharm; 1991 Apr; 19(2):175-88. PubMed ID: 1826532
[TBL] [Abstract][Full Text] [Related]
19. In-vivo clearance study of vancomycin in rats.
Nakamura T; Takano M; Yasuhara M; Inui K
J Pharm Pharmacol; 1996 Nov; 48(11):1197-200. PubMed ID: 8961172
[TBL] [Abstract][Full Text] [Related]
20. Testosterone-independent down-regulation of Oct2 in the kidney medulla from a uranyl nitrate-induced rat model of acute renal failure: effects on distribution of a model organic cation, tetraethylammonium.
Shim WS; Park JH; Ahn SJ; Han L; Jin QR; Li H; Choi MK; Kim DD; Chung SJ; Shim CK
J Pharm Sci; 2009 Feb; 98(2):739-47. PubMed ID: 18484100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
